CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $20.9M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$413K | |
| 2 | +$378K | |
| 3 | +$359K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$76.4K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$40K |
Top Sellers
| 1 | -$19M | |
| 2 | -$842K | |
| 3 | -$347K | |
| 4 |
CIA
Choate Investment Advisors
Boston,
Massachusetts
|
-$224K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$78.4K |